Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
-
AstraZeneca and Forest Laboratories to Co-Develop and Commercialise a Late Stage Next Generation Anti-Infective
-
AstraZeneca And Astellas Enter Agreement for Co-Promotion of Symbicort Turbuhaler in Japan
-
FDA Approves ONGLYZA For The Treatment Of Type 2 Diabetes In The US
-
AstraZeneca PLC Second Quarter & Half Year Results 2009
-
AstraZeneca Terminates License Agreement with MAP Pharmaceuticals Regarding Unit Dose Budesonide
-
AstraZeneca to Advance AZD3480 in ADHD
-
IRESSA (Gefitinib) Receives Marketing Authorisation for the Treatment of Non-Small Cell Lung Cancer in Europe
-
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
AstraZeneca Development Partner, Pozen, Inc., Submits New Drug Application for PN400
-
ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
Latest articles and press releases
All of our latest press releases and articles are available to explore
